These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases. Cantagrel V; Lefeber DJ J Inherit Metab Dis; 2011 Aug; 34(4):859-67. PubMed ID: 21384228 [TBL] [Abstract][Full Text] [Related]
11. SRD5A3-CDG: 3D structure modeling, clinical spectrum, and computer-based dysmorphic facial recognition. Ben Ayed I; Ouarda W; Frikha F; Kammoun F; Souissi A; Ben Said M; Bouzid A; Elloumi I; Hamdani TM; Gharbi N; Baklouti N; Guirat M; Mejdoub F; Kharrat N; Boujelbene I; Abdelhedi F; Belguith N; Keskes L; Gibriel AA; Kamoun H; Triki C; Alimi AM; Masmoudi S Am J Med Genet A; 2021 Apr; 185(4):1081-1090. PubMed ID: 33403770 [TBL] [Abstract][Full Text] [Related]
12. SRD5A3-CDG: A Patient with a Novel Variant and Brain Neoplasm. Kasapkara CS; Olgac A; Derinkuyu BE; Oztoprak U; Jaeken J J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS221-SS226. PubMed ID: 36597345 [TBL] [Abstract][Full Text] [Related]
14. A new role for dolichol isoform profile in the diagnostics of CDG disorders. Zdrazilova L; Kuchar L; Ondruskova N; Honzik T; Hansikova H Clin Chim Acta; 2020 Aug; 507():88-93. PubMed ID: 32289257 [TBL] [Abstract][Full Text] [Related]
15. Regulation of dolichol-linked glycosylation. Welti M Glycoconj J; 2013 Jan; 30(1):51-6. PubMed ID: 22717794 [TBL] [Abstract][Full Text] [Related]
16. Association of Steroid 5α-Reductase Type 3 Congenital Disorder of Glycosylation With Early-Onset Retinal Dystrophy. Taylor RL; Arno G; Poulter JA; Khan KN; Morarji J; Hull S; Pontikos N; Rueda Martin A; Smith KR; Ali M; Toomes C; McKibbin M; Clayton-Smith J; Grunewald S; Michaelides M; Moore AT; Hardcastle AJ; Inglehearn CF; Webster AR; Black GC; JAMA Ophthalmol; 2017 Apr; 135(4):339-347. PubMed ID: 28253385 [TBL] [Abstract][Full Text] [Related]
17. Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation. Lieu MT; Ng BG; Rush JS; Wood T; Basehore MJ; Hegde M; Chang RC; Abdenur JE; Freeze HH; Wang RY Mol Genet Metab; 2013 Dec; 110(4):484-9. PubMed ID: 24144945 [TBL] [Abstract][Full Text] [Related]
18. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. Thiel C; Schwarz M; Peng J; Grzmil M; Hasilik M; Braulke T; Kohlschütter A; von Figura K; Lehle L; Körner C J Biol Chem; 2003 Jun; 278(25):22498-505. PubMed ID: 12684507 [TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. Kahrizi K; Hu CH; Garshasbi M; Abedini SS; Ghadami S; Kariminejad R; Ullmann R; Chen W; Ropers HH; Kuss AW; Najmabadi H; Tzschach A Eur J Hum Genet; 2011 Jan; 19(1):115-7. PubMed ID: 20700148 [TBL] [Abstract][Full Text] [Related]
20. Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG. van Tol W; Michelakakis H; Georgiadou E; van den Bergh P; Moraitou M; Papadimas GK; Papadopoulos C; Huijben K; Alsady M; Willemsen MA; Lefeber DJ J Inherit Metab Dis; 2019 Sep; 42(5):984-992. PubMed ID: 30931530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]